All patients | ESC 2014 risk category | ||||
Low | Intermediate-low | Intermediate-high | High | ||
Subjects | 906 | 196 | 333 | 272 | 105 |
Age years | 68±16 (18–98) | 59±16 (18–80) | 70±16 (18–94) | 71±16 (23–98) | 72±15 (19–94) |
Male | 417 (46) | 109 (56) | 150 (45) | 108 (40) | 50 (48) |
RVD | 535/906 (59) | 81/196 (41) | 110/333 (33) | 272/272 (100) | 72/105 (69) |
Increased troponin | 487/905 (54) | 59/196 (30) | 92/333 (28) | 272/272 (100) | 64/105 (61) |
Thrombolytic therapy | 87/841 (10) | 13/304 (4) | 33/255 (13) | 41/99 (41) | |
Known cancer | 174/906 (19) | 99/333 (30) | 56/272 (21) | 19/105 (18) | |
COPD | 108/906 (12) | 54/333 (16) | 38/272 (14) | 16/105 (15) | |
Recent surgery | 78/829 (9) | 11/186 (6) | 28/308 (7) | 25/237 (10) | 14/98 (14) |
Recent trauma | 46/730 (6) | 12/159 (7) | 15/264 (6) | 17/217 (8) | 2/90 (2) |
Data are presented as n, mean±sd (range), n (%) or n/N (%). RVD: right ventricle dysfunction; COPD: chronic obstructive pulmonary disease.